当前位置:首页 - 行情中心 - 禾元生物-U(688765) - 财务分析 - 现金流量表

禾元生物-U

(688765)

  

流通市值:28.67亿  总市值:142.43亿
流通股本:7197.09万   总股本:3.58亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金33,834,137.4415,065,358.0156,017,967.124,014,868.56
  收到的税费返还158,981.6893,543.561,107,161.41,025,084.97
  收到其他与经营活动有关的现金30,402,700.064,135,658.497,027,306.7270,396,274.12
  经营活动现金流入小计64,395,819.1819,294,559.97154,152,435.2295,436,227.65
  购买商品、接受劳务支付的现金92,150,256.4434,883,707.0668,688,600.2475,359,601.98
  支付给职工以及为职工支付的现金34,079,943.2220,523,576.6251,027,056.9937,213,504.84
  支付的各项税费2,677,032.551,730,099.032,207,161.131,581,861.81
  支付其他与经营活动有关的现金30,746,804.3111,680,389.85160,548,582.24100,151,154.34
  经营活动现金流出小计159,654,036.5268,817,772.56282,471,400.6214,306,122.97
  经营活动产生的现金流量净额-95,258,217.34-49,523,212.59-128,318,965.38-118,869,895.32
二、投资活动产生的现金流量:
  收回投资收到的现金800,830,00075,000,000--
  投资活动现金流入的平衡项目00--
  投资活动现金流入小计800,830,00075,000,000--
  购建固定资产、无形资产和其他长期资产支付的现金333,715,157.95233,847,042.4538,058,635.46331,602,803.67
  投资支付的现金--1,310,830,000-
  投资活动现金流出小计333,715,157.95233,847,042.41,848,888,635.46331,602,803.67
  投资活动产生的现金流量净额467,114,842.05-158,847,042.4-1,848,888,635.46-331,602,803.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,456,908,042.2-
  取得借款收到的现金322,299,20524,900,000411,587,096.13406,587,096.13
  筹资活动现金流入小计322,299,20524,900,0002,868,495,138.33406,587,096.13
  偿还债务支付的现金332,199,342.9883,253,227.98321,809,094.4723,512,424.03
  分配股利、利润或偿付利息支付的现金4,014,169.81,933,586.6914,495,870.0610,012,885.64
  支付其他与筹资活动有关的现金4,456,9542,060,00045,915,781.718,150,707.81
  筹资活动现金流出小计340,670,466.7887,246,814.67382,220,746.2441,676,017.48
  筹资活动产生的现金流量净额-18,371,261.78-62,346,814.672,486,274,392.09364,911,078.65
四、汇率变动对现金及现金等价物的影响-26,615.02239.62-27,873.47-22,430.7
五、现金及现金等价物净增加额353,458,747.91-270,716,830.04509,038,917.78-85,584,051.04
  加:期初现金及现金等价物余额669,441,252.44669,441,252.44160,402,334.66160,402,334.66
  期末现金及现金等价物余额1,022,900,000.35398,724,422.4669,441,252.4474,818,283.62
补充资料:
  净利润-62,756,540.53--157,037,347.83-
  资产减值准备960,008.16-705,891.77-
  固定资产和投资性房地产折旧29,262,100.8-59,075,705.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧29,262,100.8-59,075,705.14-
  无形资产摊销1,301,432.1-2,802,836.08-
  长期待摊费用摊销364,957.3-723,013.23-
  处置固定资产、无形资产和其他长期资产的损失-1,311,595.48--3,788,302.22-
  财务费用1,742,632.38-7,559,677.76-
  投资损失-8,060,063.39--907,526.05-
  存货的减少-123,819,282.07--73,339,498.69-
  经营性应收项目的减少-40,122,796.42--77,559,983.99-
  经营性应付项目的增加93,501,420.27-86,510,149.25-
  其他8,581,239.67-23,156,127.89-
  现金的期末余额1,022,900,000.35-669,441,252.44-
  减:现金的期初余额669,441,252.44-160,402,334.66-
  现金及现金等价物的净增加额353,458,747.91-509,038,917.78-
公告日期2026-08-272026-04-282026-04-282025-10-24
审计意见(境内)标准无保留意见
TOP↑